Rheumatology Aymen A Kenawy Md Dr is categorized under Rheumatologists in Panama City, FL and active since 2011.
Rheumatology Aymen A Kenawy Md Dr was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Rheumatologists business, which does work in the B2C market, and is classified as a Rheumatologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Aymen Ahmed Kenawy at the company’s single location by writing to 2202 State Avenue, Panama City, Florida FL 32405 or by phoning (850) 215-6400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rheumatology Aymen A Kenawy Md Dr |
| Contact Person: | Aymen Ahmed Kenawy |
| Address: | 2202 State Avenue, Panama City, Florida 32405 |
| Phone Number: | (850) 215-6400 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Rheumatologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Rheumatology Aymen A Kenawy Md Dr was started in 2011 to provide professional Rheumatologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Aymen Ahmed Kenawy for inquiries that concern Rheumatology Aymen A Kenawy Md Dr by calling the company number (850) 215-6400, as your correspondence is most welcome. Additionally, the physical location of the single location of Rheumatology Aymen A Kenawy Md Dr can be found at the coordinates 30.187649,-85.666619 as well as the street address 2202 State Avenue in Panama City, Florida 32405.
For its online presence, you may visit Rheumatology Aymen A Kenawy Md Dr’s website at and engage with its social media outlets through on Twitter and on Facebook.